IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,206 | -12.3% | 215,925 | +1.3% | 0.03% | -6.9% |
| Q2 2023 | $12,776 | +19.0% | 213,083 | -1.8% | 0.03% | +11.5% |
| Q1 2023 | $10,732 | -12.0% | 217,057 | +1.5% | 0.03% | -18.8% |
| Q4 2022 | $12,199 | -99.9% | 213,768 | +1.9% | 0.03% | +18.5% |
| Q3 2022 | $9,851,000 | -28.5% | 209,871 | -43.2% | 0.03% | -27.0% |
| Q2 2022 | $13,786,000 | +18.9% | 369,504 | -4.7% | 0.04% | +60.9% |
| Q1 2022 | $11,592,000 | -4.7% | 387,694 | +9.2% | 0.02% | 0.0% |
| Q4 2021 | $12,158,000 | -6.4% | 355,083 | +1.4% | 0.02% | -11.5% |
| Q3 2021 | $12,983,000 | -4.7% | 350,214 | +0.4% | 0.03% | -7.1% |
| Q2 2021 | $13,621,000 | -0.1% | 348,814 | +8.9% | 0.03% | -6.7% |
| Q1 2021 | $13,633,000 | – | 320,252 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |